Coenzyme Q10 levels in maternal plasma and cord blood:: Correlations with mode of delivery

被引:15
|
作者
Compagnoni, G
Lista, G
Giuffrè, B
Mosca, F
Marini, A
机构
[1] ICP, Dept Neonatol, Milan, Italy
[2] Univ Milan, Inst Pediat & Neonatol, Milan, Italy
来源
BIOLOGY OF THE NEONATE | 2004年 / 86卷 / 02期
关键词
coenzyme Q(10); oxygen; Neonate; vaginal delivery; caesarean section; spinal anaesthesia; general anaesthesia;
D O I
10.1159/000078382
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: Oxygen (O-2) plays a critical role in the O-2-reduction reactions indispensable for life, but can produce free radicals that are involved in many diseases. Coenzyme Q(10) (CoQ(10)), acting as a redox carrier in the respiratory chain, occupies a central position in the energy metabolism and oxidative defence. Neonates seem to be very subjected to oxidative stress because of their deficient antioxidant systems. Design/Methods: The aim of the study was to verify whether the mode of delivery may affect CoQ10 levels in the mother and neonate, and thus influence the risk of oxidative damage in the newborn. We measured CoQ10 levels in maternal plasma and cord blood at birth after three different modes of delivery (45 term healthy pregnancies): (1) vaginal in room air (VD) (n = 15); (2) elective caesarean section with general anaesthesia (50% O-2 and 50% N2O) (CSg) (n = 15), and (3) elective caesarean section with spinal anaesthesia without O-2 (CSs) (n = 15). Our results showed higher levels of Q(10) in mothers and neonates with VD (1.29 +/- 0.43 and 0.15 +/- 0.06 mug/ml, respectively) or CSs (1.15 +/- 0.28 and 0.24 +/- 0.06 mug/ml, respectively) when compared to CSg (0.74 +/- 0.28 and 0.07 +/- 0.03 mug/ml, respectively) (p < 0.01). Conclusions: These data demonstrate that the mode of delivery may affect CoQ(10) levels in mothers and neonates, and thus influence the risk of oxidative damage in the newborn. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码:104 / 107
页数:4
相关论文
共 50 条
  • [31] Plasma coenzyme Q10 levels in type 2 diabetic patients with retinopathy
    Orhan Ates
    Habip Bilen
    Sadullah Keles
    H.Hakan Alp
    Mevlüt Sait Keles
    Kenan Yildirim
    Osman ndas
    L.Can Pinar
    Mustafa Civelekler
    Orhan Baykal
    International Journal of Ophthalmology, 2013, 6 (05) : 675 - 679
  • [32] Comparison of coenzyme Q10 plasma levels in obese and normal weight children
    Menke, T
    Niklowitz, P
    de Sousa, G
    Reinehr, T
    Andler, W
    CLINICA CHIMICA ACTA, 2004, 349 (1-2) : 121 - 127
  • [33] Coenzyme Q10
    Vormann, J
    AGRO FOOD INDUSTRY HI-TECH, 2004, 15 (03): : 34 - 37
  • [34] Coenzyme Q10
    不详
    JOURNAL OF COMPLEMENTARY MEDICINE, 2008, 7 (01): : 36 - +
  • [35] Coenzyme Q10
    不详
    ALTERNATIVE MEDICINE REVIEW, 2007, 12 (02) : 159 - 168
  • [36] Coenzyme Q10
    Bonakdar, RA
    Guarneri, E
    AMERICAN FAMILY PHYSICIAN, 2005, 72 (06) : 1065 - 1070
  • [37] Estimation of plasma and saliva levels of coenzyme Q10 and influence of oral supplementation
    Sekine, K.
    Ota, N.
    Nishii, M.
    Uetake, T.
    Shimadzu, M.
    BIOFACTORS, 2005, 25 (1-4) : 205 - 211
  • [38] Effect of ezetimibe and/or simvastatin on coenzyme Q10 levels in plasma - A randomised trial
    Berthold, Heiner K.
    Naini, Ali
    Di Mauro, Salvatore
    Hallikainen, Maarit
    Gylling, Helena
    Krone, Wilhelm
    Gouni-Berthold, Ioanna
    DRUG SAFETY, 2006, 29 (08) : 703 - 712
  • [39] PEGylated Solanesol for Oral Delivery of Coenzyme Q10
    Qin, Benkai
    Liu, Lei
    Pan, Yangyang
    Zhu, Yingchun
    Wu, Xiaohe
    Song, Shiyong
    Han, Guang
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2017, 65 (16) : 3361 - 3368
  • [40] Coenzyme Q10
    Pepping, J
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 (06) : 519 - 521